1. Introduction {#sec1}
===============

In recent years, traditional Chinese medicine (TCM) has attracted increasing attention worldwide by virtue of its applications. *Da Chuanxiong Formula* (DCXF) is a well-known and extensively used traditional Chinese medicine (TCM) decoction for the treatment of migraine caused by blood stasis and wind-heat syndrome. It is composed of two herbs, namely, Chuanxiong (*Chuanxiong rhizoma*) and Tianma (*Gastrodiae rhizoma*), with a crude weight ratio of 4 : 1. Tianshu tablets (TST) are a representative DCXF preparation that is widely used in clinics for treating the blood stasis type of headache and migraine \[[@B1]--[@B3]\].

Phytochemical and pharmacological investigations of DXCF have shown that phenols, organic acids, phthalides, and nitrogen-containing compounds are the major active ingredients \[[@B4]\]. At present, several qualitative studies on the main components of DCXF have been performed \[[@B5]--[@B8]\]. One study used LC-Q-TOF/MS to identify 17 different components in a 50% ethanol extract of DCXF \[[@B5]\]. In one study, three compounds of Chuanxiong and eight components of Tianma were identified by HPLC-DAD-MS^n^ \[[@B6]\]. Two continuous studies showed that 10 different compounds were detected in rat plasma after intragastric administration of DCXF active components, including 6 compounds from Chuanxiong and 4 compounds from Tianma \[[@B7], [@B8]\]. These four studies were based on samples of a 50% ethanol extract from a 4 : 1 mixture of the two herbs or active ingredients from a single crude herb. In one study, 38 components were identified or preliminarily identified from a Tianshu capsule by means of HPLC, LC-DAD-MSN, and LC-DAD-ESI IT-TOF/MS analysis, although Tianshu tablets and Tianshu capsules are two different dosage forms \[[@B9]\]. This research is still very important because of its different applicability. This study enriches our understanding of the components of DCXF and studies the metabolites of TST for the first time.

In our study, 77 chemical components of TST were preliminarily determined by a comparison with retention time, accurate molecular mass, and characteristic fragment ions of known compounds in the literature. Furthermore, UPLC/Q-TOF MS was used to analyze the plasma of rats after oral administration of TST. A total of 61 compounds were identified or preliminarily identified, including 7 prototypes and 54 metabolites.

2. Experimental {#sec2}
===============

2.1. Chemicals and Materials {#sec2.1}
----------------------------

Some reference standards (pyroglutamic acid, 5-(hydroxymethyl)furoic acid, and parishin B) for *Gastrodia rhizoma* were isolated and purified in our laboratory, and other standards (uridine, gastrodin A, and neocnilide) were purchased from the National Institutes for Food and Drug Control (Beijing, China). Purities of the standards were above 98% by HPLC analysis. HPLC-grade acetonitrile, methanol, and formic acid were purchased from Fisher Scientific (MA, USA). Deionized water was prepared by a Milli-Q Water purification system (Millipore, MA, USA). High-purity nitrogen (99.99%) and helium (99.999%) were purchased from Gas Supplies Center of Peking University Health Science Center (Beijing, China).

*Gastrodia rhizoma* and *Chuanxiong rhizoma* were purchased from Tian Heng pharmacy (Beijing, China). All herbal materials were authenticated by Professor Bei Wu (Nanchang Institute for Food and Drug Control). TianShu tablets were prepared according to Chinese Pharmacopoeia 2015 Edition \[[@B1]\].

2.2. Animals and Drug {#sec2.2}
---------------------

Sprague--Dawley rats (male, 12--14 weeks; 200--240 g) were provided by Hunan SJA Laboratory Animal Co., Ltd. Protocols for all animal experiments were approved. Animals were kept in a controlled environment for 3 days and fasted for 12 h before experiments. TST were dissolved in a 9 g/L NaCl solution (NS) (250 mg/ml) and administered by oral gavage at a dose of 1000 mg/kg (equivalent to 4 g of crude drug per kg) body weight.

2.3. Sample Collection and Pretreatment {#sec2.3}
---------------------------------------

After oral administration of TST, blood samples were collected at 30, 60, and 120 min (*n* = 5) in an Eppendorf tube with heparin sodium and then centrifuged (16000 rpm) at 4°C for 10 min. The supernatant was then separated, and all samples were stored at −80°C immediately until analysis. The protocol for sample preparation is described below: 1 mL plasma was mixed with 5 mL methanol, vortexed for 5 min, and centrifuged at 16000 rpm at 4°C for 20 min. The supernatant was dried with nitrogen gas at 4°C, and 400 *μ*l of 50% methanol was added to reconstitute the residue, which was then centrifuged at 16000 rpm for 10 min at 4°C. The supernatant was transferred to a vial, and 10 *μ*l was injected for LC-MS analysis. All samples were filtered through a membrane (0.22 *μ*m pore size). At the same time, in order to eliminate the influence of matrix, blank plasma was added to participate in the analysis.

2.4. UPLC/QTOF-MS Conditions {#sec2.4}
----------------------------

UPLC/QTOF-MS analysis was performed on a Shimadzu LC-30 AD system (Kyoto, Japan) coupled with an AB SCIEX Triple-TOF 5600 mass spectrometer (Foster City, CA, USA). All samples were separated on an Acquity UPLC C18 column (100 mm × 2.1 mm, 1.7 *μ*m, Waters, USA) with a flow rate of 0.3 mL/min at 40°C. The mobile phase consisted of aqueous 0.1% formic acid (A) and 0.1% formic acid in acetonitrile (B). The gradient elution program for TST was set at 0--3.0 min, 5--8% B; 3.0--10.0 min, 8--15% B; 10.0--18 min, 15--20% B; 18--22 min, 20--35% B; 22--37 min, 35--45% B; 37--43 min, 45--95% B; and 43--48 min, 95--95% B. The gradient elution program for the plasma samples was set at 0--2.0 min, 5% B; 2.0--25.0 min, 5--95% B; and 25.0--30.0 min, 95--95%. The equilibration time was 5 min. The conditions for the ion source were as follows: compounds in TST were measured using the total ion chromatograms in negative and positive ion ESI-MS mode in the mass range *m*/*z* 50--1250, but plasma samples were analyzed only in positive ion ESI-MS mode. The other operating parameters were optimized as follows: source temperature, 500°C; ion spray voltage, 4500 V; gas 1, 50 psi; gas 2, 50 psi; curtain gas, 45 psi; decluttering potential, 100 V; and collision energy was set to 40 (15) eV.

2.5. Data Process {#sec2.5}
-----------------

TST compounds from the extracts and metabolites data were acquired by full scan, which rely on dynamic background subtraction (DBS) and multiple mass defect filtering (MMDF) and includes some compounds with very low concentrations (MDF window was set to ±50 mDa around the mass defects of the templates and over a mass range of ±50 Da around the filter template masses).

Analysis of data on TST compounds in extracts and metabolites was performed using a variety of data mining tools, including extract ion chromatograms (XIC) of PeakView®1.6 (AB SCIEX, CA, USA), MMDF, and NLF&DPLs of Metabolitepilot™ 1.5 (AB SCIEX, Foster City, CA, USA). All compounds were analyzed after removal of the matrix effects.

3. Results and Discussion {#sec3}
=========================

3.1. Optimization of LC/MS Conditions {#sec3.1}
-------------------------------------

In order to obtain the best analytical data, our analysis builds upon another recent study \[[@B10]\]. The separation conditions, supplements, and chromatographic columns were optimized at the beginning of the experiment. Firstly, in order to obtain sharp peaks and reduce the pressure on the UPLC column, methanol was used as the mobile phase instead of acetonitrile. At the same time, 0.1% formic acid was added to improve peak shape and ionization of the analytes. The gradient was improved, and it was shown that the compounds in TST could be separated within 48 minutes, while plasma samples could be separated within 30 minutes (the specific methods can be found in [Section 2.4](#sec2.4){ref-type="sec"}). In addition, in order to obtain the most abundant mass spectrometry information, the collision energy was optimized. The results showed that when the collision energy rose to 40 eV, the main fragments were seen, but when the energy reached 55 eV, the second order fragments were too fragmented to be easily analyzed. Therefore, a collision energy of 40 eV was selected. As for UPLC/Q-TOF MS, mass spectra were recorded in both positive and negative detection modes.

3.2. UPLC/Q-TOF MS Analysis of TST Extracts {#sec3.2}
-------------------------------------------

To characterize the chemical constituents of TST, a fast, efficient, and reliable UPLC/Q-TOF MS method was established. By virtue of the high resolution and speed of UPLC and the accurate mass measurement of the TOF MS, a total of 77 compounds were identified. The mass spectra of these components were examined in negative ion mode and positive ion mode. The total ion chromatogram (TIC) of TST in positive and negative ion modes are shown in Figures [1](#fig1){ref-type="fig"} and [2](#fig2){ref-type="fig"}. Details of the identified components are summarized in [Table 1](#tab1){ref-type="table"}.

Through analysis, it was found that the 77 compounds contained 19 organic acids, 9 nitrogen-containing compounds, 11 glucosides, 8 phenols, 24 phthalides, and 6 other compounds. The numbering information of these compounds is shown in [Figure 3](#fig3){ref-type="fig"}.

### 3.2.1. Chemical Fingerprint of TST in Negative Ion Modes {#sec3.2.1}

According to the literature, the main components of Tianma are phenols and organic acids \[[@B9]\]. However, there are also glycosides in the components of Tianma \[[@B12]\]. Many characteristic components of Tianma were analyzed and identified in the negative ion mode. Because the structures of organic acids and phenols are relatively simple, the characteristic glycoside compounds **X18** and **X23** were identified here and the chromatographic and spectral data for compounds **X18** and **X23** were preliminarily characterized by referring to the literature and reference materials.

Peak **X18** gave an \[M−H\]^−^ ion at *m*/*z* 447.1508. Peak **X18** produced MS^2^ base peaks at *m*/*z* 269.1028 and 161.0449 corresponding to \[M-H-179 Da\]^−^. This suggests that Peak **X18** may contain a glucose group and a fructose group. Therefore, we deduced that the molecular structure likely contains sucrose. According to literature reports \[[@B12]\] and reference standards, we identified Peak **X18** as gastrodin A. Peak **X23** gave a \[M-H\]^−^ ion at *m*/*z* 727.2091 and had characteristic fragment ions at *m*/*z* 459.1156, 441.1045, 423.0937, 397.1142, 369.1188, and 217.0496. Based on previous studies \[[@B12]\] and a reference standard, Peak **X23** was identified as parishin B. The characteristic fragmentation patterns of gastrodin A and parishin B are described in Figures [4(a)](#fig4){ref-type="fig"} and [4(b)](#fig4){ref-type="fig"}.

### 3.2.2. Chemical Fingerprint of TST in Positive Ion Modes {#sec3.2.2}

The analysis of the positive ion mode results showed that the characteristic components of Chuanxiong, including phthalides, were present. Here, compound Y27 was selected for analysis, and the chromatographic and spectral data of this compound were analyzed by comparison with the literature and reference materials. The cleavage pathway of phenyl peptides in Chuanxiong was also analyzed.

Peak **Y27** gave a \[M+H\]^+^ ion at *m*/*z* 195.1378 and fragment ions at *m*/*z* 177.1344, 149.1309, and 107.0550. According to previous literature reports \[[@B9]\] and a reference standard, we identified peak **Y27** as cnidilide or neocnilide. The characteristic fragmentation pattern of **Y27** is shown in [Figure 4(c)](#fig4){ref-type="fig"}

According to our analysis, the main components of Tianma in negative ion mode were organic acids, phenols, and glycosides, with mainly phthalides detected in positive ion mode. The specific pyrolysis fragments were similar to the standards.

3.3. Detection and Identification of the Metabolites of TST in Rat Plasma {#sec3.3}
-------------------------------------------------------------------------

In order to identify as many potential pharmacologically active compounds as possible in TST, metabolic profiling of TST in rat plasma was performed. Compounds absorbed in vivo can be further metabolized by a variety of enzymes through oxidation, hydrolyzation, methylation, glucuronidation, and sulfation. Only peaks that were detected in the dosed plasma samples but not in blank samples were considered as probable metabolites. The mass spectra of the metabolites were examined in positive ion mode. These were further analyzed by using Peakview 1.2 to identify expected and unexpected metabolites from different metabolic pathways, and their structures were identified by tandem MS. We selected senkyunolide D or 4,7-dihydroxy-3-butylphthalide and senkyunolide A as examples of the structural identification process. The metabolites of these compounds and others are summarized in [Table 2](#tab2){ref-type="table"}, and their TIC and extract ion chromatogram (EICs) are shown in Figures [5](#fig5){ref-type="fig"}[](#fig6){ref-type="fig"}[](#fig7){ref-type="fig"}--[8](#fig8){ref-type="fig"}.

Metabolite **M1**, which eluted at 9.75 min, formed a molecular ion of \[M+H\]^+^ at *m*/*z* 223.0963 corresponding to C~12~H~14~O~4~. **M1** was found to have major fragment ions in common with senkyunolide D, so **M1** is most likely senkyunolide D or 4,7-dihydroxy-3-butylphthalide. Metabolite **M2**, which eluted at 10.78 min, formed a molecular ion of \[M+H\]^+^ at *m*/*z* 253.1071 corresponding to C~13~H~16~O~5~. The characteristic production of *m*/*z* 235.0963 and 221.0839 was generated by loss of 18 Da and 18 + 14 Da, which implied loss of a H~2~O group and methyl group. Other product ions were identical to that of **M1**. Therefore, **M2** may be a metabolite of senkyunolide D after hydroxyl and methyl conjugation. Metabolite **M3**, which eluted at 9.2 min, formed a molecular ion of \[M+H\]^+^ at *m*/*z* 303.0535 corresponding to C~12~H~14~SO~7~. Its major fragment ions at *m*/*z* 285.0430 and 205.0858 were generated by the loss of 18 Da and 18 + 80 Da, which implied a H~2~O group and sulfate group. Other product ions were identical to that of **M1**. Therefore, **M3** may be a metabolite of senkyunolide D following sulfation. Metabolite **M4**, which eluted at 10.6 min, formed a molecular ion of \[M+H\]^+^ at *m*/*z* 399.1285 corresponding to C~18~H~22~O~10~. Its major fragment ion (*m*/*z* 223.0969) was generated by a loss of 176 Da, which implied a glucuronide group. Other product ions were identical to that of **M1**. Therefore, **M4** might be a metabolite of senkyunolide D after glucuronidation. Metabolites **M5** and **M6** appear to correspond to **M4** plus 2 Da or 16 Da, respectively. The product ions *m*/*z* 225.4427 and *m*/*z* 227.0584 have both lost 176 Da. Therefore, **M5** might be a metabolite of senkyunolide D after hydrogenation and glucuronidation, while **M6** might be a metabolite of senkyunolide D after hydroxylation and glucuronidation (metabolites of **M1** and extract ion chromatograms (EICs) are shown in [Figure 6](#fig6){ref-type="fig"}).

Metabolite **M27**, which eluted at 14.81 min, formed a molecular ion of \[M+H\]^+^ at *m*/*z* 193.1222 corresponding to C~12~H~16~O~2~. A major fragment ion was shared with senkyunolide A, suggesting that **M27** is prototype of senkyunolide A. Metabolite **M28**, which eluted at 14.81 min, formed a molecular ion of \[M+H\]^+^ at *m*/*z* 223.1328 corresponding to C~13~H~18~O~3~. Its major fragment ions *m*/*z* 205.1224 and 191.1060 were generated by loss of 18 Da and 18 + 14 Da, which implied loss of a H~2~O group and methyl group. Other product ions were identical to that of **M27**. Based on the possible metabolic reactions, **M28** might be a metabolite of senkyunolide A after hydroxylation and methylation. Metabolite **M29**, which eluted at 10.35 min, formed a molecular ion of \[M+H\]^+^ at *m*/*z* 372.1475 corresponding to C~17~H~25~O~6~NS. Its major fragment ions *m*/*z* 209.1269 and 191.1074 were generated by loss of 163 Da and 163 + 18 Da, which implied loss of an acetylcysteine group and H~2~O group. Other product ions were identical to that of **M27**. Therefore, **M29** may be a metabolite of senkyunolide A after hydroxyl and acetylcysteine conjugation. Metabolite **M30**, which eluted at 10.60 min, formed a molecular ion of \[M+H\]^+^ at *m*/*z* 399.1285 corresponding to C~18~H~22~O~10~. Its major fragment ions *m*/*z* 223.0969, 205.0847, and 177.0883 were generated by the loss of 176 Da, 176 + 18 Da, and 176 + 18 + 28 Da, which implied loss of a glucuronide group, H~2~O group, and CO group. Other product ions were identical to that of **M27**. Therefore, **M30** may be a metabolite of senkyunolide A following carboxylation and glucuronidation. Metabolite **M31**, which eluted at 8.67 min, formed a molecular ion of \[M+H\]^+^ at *m*/*z* 401.1444 corresponding to C~18~H~24~O~10~. Its major fragment ions *m*/*z* 225.1127, 207.1017, and 189.0924 were generated by loss of 176 Da, 176 + 18 Da, and 176 + 18 + 18 Da, which implied loss of a glucuronide group and two H~2~O groups. Other product ions were identical to that of **M27**. Therefore, **M31** might be a metabolite of senkyunolide A after 2 hydroxylation events and glucuronidation. Metabolite **M32**, which eluted at 10.54 min, formed a molecular ion of \[M+H\]^+^ at *m*/*z* 211.1327 corresponding to C~12~H~18~O~3~. Its major fragment ions were *m*/*z* 193.1225 and 175.1096. An *m*/*z* of 193.1225 (loss of 18 Da) corresponds to senkyunolide A, suggesting that **M32** might be a metabolite of senkyunolide A after H~2~O conjugation. Metabolite **M33**, which eluted at 9.56 min, formed a molecular ion of \[M+H\]^+^ at *m*/*z* 225.1119 corresponding to C~12~H~16~O~4~. Its major fragment ions *m*/*z* 207.1013 and 189.0914 were generated by loss of 18 Da and 18 + 18 Da, which implied loss of one or two H~2~O groups. Other product ions were identical to that of **M27**. Therefore, **M33** might be a metabolite of senkyunolide A after 2 hydroxylation events (metabolites of **M27** and extracted ion chromatograms (EICs) are shown in [Figure 7](#fig7){ref-type="fig"}).

Sixty-one metabolites were identified in rat plasma. Through the analysis of these 61 metabolites, it was found that hydroxylation and glucuronidation were the main metabolic ways following oral administration of TST. From the identified metabolites, it can be speculated that after absorption of TST by human blood, most of the compounds undergo hydroxylation and glucuronidation, which allow TST to play a positive role in the treatment of migraine and blood stasis headaches. This provides a basis for follow-up research on the medical uses of TST. At the same time, from the information obtained on the metabolites, it can be seen that the main metabolites in positive ion mode of TST are concentrated as chuanxiong lactones, but there are no effective metabolites from Tianma. It is possible that Tianma metabolites are mainly present in the negative ion mode of plasma or in feces, urine, and bile, which requires further study.

4. Conclusion {#sec4}
=============

In this study, UPLC/Q-TOF MS was used to comprehensively determine the chemical fingerprint and metabolic profile of TST after intragastric administration. In the analysis of the chemical constituents of TST, 77 compounds were identified, including 39 compounds identified in negative ion mode and 38 compounds identified in positive ion mode. In order to elucidate the mass spectrometric pyrolysis law of the main compounds in TST, gastrodin A, parishin B, and cnidilide or neocnilide were specifically analyzed, and the results were completely consistent with the results in reference standards and the reported literature. And 61 metabolites of TST in rat plasma were detected, which were mainly metabolites of 7 compounds. Two prototypes (senkyunolide D or 4,7-dihydroxy-3-butylphthalide and senkyunolide A) and their metabolites were analyzed in detail, which showed hydroxylation and glucuronidation were the main metabolic pathways following oral administration. This study expanded our understanding of the chemical constituents of TST, studied its metabolic spectrum for the first time, and clarified its main metabolic pathway in plasma, which will lay the foundation for follow-up studies of the pharmacological mechanism of TST.
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![MS total ion chromatogram (TIC) of TST fraction by UPLC/Q-TOF MS in negative ion mode.](JAMC2019-9158942.001){#fig1}

![MS total ion chromatogram (TIC) of TST fraction by UPLC/Q-TOF MS in positive ion mode.](JAMC2019-9158942.002){#fig2}
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![MS/MS spectra and the proposed fragmentation pathways. (a) Parishin B in negative ion mode. (b) Gastrodin A in negative ion mode. (c) Cnidilide or neocnilide in positive ion mode.](JAMC2019-9158942.004){#fig4}

![MS total ion chromatogram (TIC) of metabolites by UPLC/Q-TOF MS.](JAMC2019-9158942.005){#fig5}

![Metabolites of M1 and extract ion chromatogram (EIC).](JAMC2019-9158942.006){#fig6}

![Metabolites of M27 and extract ion chromatogram (EIC).](JAMC2019-9158942.007){#fig7}

![The extract ion chromatograms (EICs) of other metabolites detected.](JAMC2019-9158942.008){#fig8}

###### 

The chemical constituents detected from TST.

  Peak         RT (min)   Formula                Error (ppm)   \[M−H\]^−^ (*m*/*z*)   Intensity   Product ions   Identification                                                                                      Structure class                                                                              Ref.                            
  ------------ ---------- ---------------------- ------------- ---------------------- ----------- -------------- --------------------------------------------------------------------------------------------------- -------------------------------------------------------------------------------------------- ------------------------------- ------------
  X1^a^        0.98       C~7~H~12~O~6~          −1.2          191.0561               191.0559    86129          154.9973, 127.0393, 111.0091, 93.0355, 85.0302, 73.0302                                             Quinic acid                                                                                  Organic acids                   \[[@B10]\]
  X2           1.07       C~6~H~8~O~7~           0.9           191.0197               191.0199    421357         111.0096, 87.0103                                                                                   Citric acid                                                                                  Organic acids                   \[[@B10]\]
  X3^b^        1.07       C~9~H~12~N~2~O~6~      −1            243.0623               243.0620    5161           nd                                                                                                  Uridine                                                                                      Nitrogen-containing compounds    
  X4^b^        1.08       C~5~H~7~NO~3~          3             128.0353               128.0357    24352          nd                                                                                                  Pyroglutamic acid                                                                            Organic acids                    
  X5^b^        1.36       C~6~H~6~O~4~           1.1           141.0193               141.0195    3248           nd                                                                                                  5-(Hydroxymethyl)furoic acid                                                                 Organic acids                   \[[@B11]\]
  X6           1.36       C~10~H~13~N~5~O~5~     2.4           282.0844               282.0851    1153           150.0412, 133.0158, 108.0286                                                                        Guanosine                                                                                    Nitrogen-containing compounds    
  X7           1.63       C~13~H~18~O~7~         −1.1          285.0980               285.0977    1505           223.0248, 123.0432, 105.0348                                                                        Gastrodin                                                                                    Glycosides                      \[[@B12]\]
  X8           2.03       C~7~H~6~O~4~           0.7           153.0193               153.0195    16114          109.0300, 91.0193, 65.0057                                                                          Protocatechuic acid                                                                          Organic acids                   \[[@B13]\]
  X9           4.02       C~7~H~6~O~3~           2.5           137.0244               137.0248    31464          119.0140, 108.0215, 93.0350, 81.0366, 65.0414                                                       3,4-Dihydroxy benzaldehyde                                                                   Phenols                         \[[@B14]\]
  X10          4.70       C~19~H~24~O~13~        1.7           459.1144               459.1152    283440         423.0939, 397.1138, 173.0088, 61.0444, 129.0184, 111.0088                                           Parishin E or G                                                                              Glycosides                      \[[@B12]\]
  X11          5.09       C~16~H~18~O~9~         0.8           353.0878               353.0881    109164         191.0559, 173.0444, 161.0236, 134.0387, 111.0458, 93.0350, 85.0301                                  4-Caffeoylquinic acid                                                                        Organic acids                   \[[@B15]\]
  X12          5.13       C~17~H~23~N~3~O~7~S    0.5           412.1184               412.1186    11210          306.0753, 272.0898, 179.0459, 160.0077, 143.0461, 128.0348, 99.0559                                 *S*-(4-Hydroxybenzyl)-glutathione                                                            Nitrogen-containing compounds   \[[@B12]\]
  X13          5.24       C~23~H~33~N~3~O~12~S   2.3           574.1712               574.1726    7677           484.1388, 378.0974, 306.0756, 272.0874, 210.0864, 143.0464                                          *S*-(4-Hydroxybenzyl)-glutathione glucoside                                                  Nitrogen-containing compounds    
  X14          5.34       C~9~H~10~O~4~          −0.2          181.0506               181.0506    2573           136.9210, 121.0296, 109.0279                                                                        4-(2-Hydroxyethoxy)benzoic acid                                                              Organic acids                    
  X15          5.58       C~7~H~6~O~2~           4.3           121.0295               121.0302    50808          92.0266, 77.0403                                                                                    *p*-Hydroxybenzaldehyde                                                                      Phenols                         \[[@B14]\]
  X16          5.64       C~9~H~8~O~4~           0.9           179.0350               179.0352    80360          134.0371, 108.0214, 93.0345, 89.0401, 79.0555                                                       Caffeic acid                                                                                 Organic acids                   \[[@B13]\]
  X17          5.99       C~8~H~8~O~4~           3             167.0350               167.0355    275549         123.0454, 79.0570                                                                                   Vanillic acid                                                                                Organic acids                   \[[@B12]\]
  X18^b^       7.31       C~19~H~28~O~12~        0.4           447.1508               447.1510    14270          269.1028, 233.0656, 161.0449, 101.0242, 71.0153                                                     Gastrodin A                                                                                  Glycosides                      \[[@B12]\]
  X19          7.68       C~17~H~19~N~5~O~5~     −1.6          372.1313               372.1307    2202           336.1054, 266.0867, 134.0467                                                                        *p*-Hydroxybenzyl adenosine                                                                  Nitrogen-containing compounds    
  X20          7.73       C~8~H~8~O~3~           0.5           151.0401               151.0402    7660           136.0155, 108.0219, 92.0273                                                                         Vanilline                                                                                    Phenols                          
  X21          8.62       C~17~H~20~O~9~         −0.7          367.1035               367.1032    21071          193.0496, 191.0553, 173.0455, 134.0369, 111.0463, 93.0349, 85.0299                                  3-Feruloylquinic acid                                                                        Organic acids                   \[[@B16]\]
  X22          8.94       C~9~H~10~O~3~          −0.8          165.0557               165.0556    2085           119.0515, 103.0604                                                                                  L-(-)-Phenyllactic acid                                                                      Organic acids                    
  X23^b^       9.11       C~32~H~40~O~19~        4.9           727.2091               727.2151    122722         459.1156, 441.1045, 423.0937, 397.1142, 369.1188, 217.0496                                          Parishin B                                                                                   Glycosides                      \[[@B13]\]
  X24          9.78       C~33~H~42~O~20~        4             757.2197               757.2227    659            503.1631, 453.0961, 161.0480                                                                        Parishin H or M                                                                              Glycosides                      \[[@B12]\]
  X25          10.00      C~10~H~10~O~4~         0.7           193.0506               193.0508    97733          178.0265, 149.0591, 134.0372                                                                        Ferulic acid                                                                                 Organic acids                   \[[@B13]\]
  X26          10.02      C~21~H~28~O~13~        0             487.1457               487.1457    4684           441.0958, 423.0934, 397.1169, 161.0430, 111.0091                                                    Parishin O or N                                                                              Glycosides                      \[[@B12]\]
  X27          10.05      C~32~H~40~O~19~        4.9           727.2091               727.2127    122722         459.1156, 441.1045, 423.0937, 397.1142, 369.1188, 161.0453                                          Parishin C                                                                                   Glycosides                      \[[@B12]\]
  X28          10.71      C~14~H~14~O~3~S        −2.2          261.0591               261.0585    777            205.8269, 167.8694, 137.0057                                                                        4,4′-Dihydroxybenzyl sulfoxide                                                               Phenols                         \[[@B14]\]
  X29          11.74      C~11~H~12~O~5~         −2.2          223.0612               223.0607    2431           108.0226, 179.0713                                                                                  Sinapic acid                                                                                 Organic acids                   \[[@B13]\]
  X30          12.20      C~7~H~6~O~3~           2.5           137.0244               137.0248    31464          108.0215, 93.0352, 65.0410                                                                          *p*-Hydroxybenzoic acid                                                                      Phenols                         \[[@B14]\]
  X31          13.21      C~45~H~56~O~25~        4.7           995.3038               995.3107    39727          727.2129, 441.1065, 423.0915, 397.1119, 161.0457                                                    Parishin                                                                                     Glycosides                      \[[@B12]\]
  X32          13.56      C~20~H~24~O~8~         0.2           391.1398               391.1399    6858           229.0860, 123.0452, 121.0288, 107.0511, 93.0357, 71.0265                                            Bis-(4-hydroxybenzyl)-ether-mono-β-D-glucopyranoside                                         Glycosides                      \[[@B14]\]
  X33          13.69      C~26~H~30~O~14~        2.9           565.1563               565.1579    811            177.0188, 111.0153                                                                                  Parishin W                                                                                   Glycosides                      \[[@B12]\]
  X34          14.13      C~25~H~24~O~12~        2.6           515.1195               515.1208    91406          353.0879, 335.0781, 191.0558, 179.0345, 173.0450, 161.0240                                          3,4-Dicaffeoylquinic acid isomer                                                             Organic acids                   \[[@B15]\]
  X35          16.48      C~25~H~24~O~12~        2.6           515.1195               515.1208    91406          353.0879, 335.0781, 191.0558, 179.0345, 173.0450, 161.0240                                          3,4-Dicaffeoylquinic acid isomer                                                             Organic acids                   \[[@B15]\]
  X36          17.42      C~9~H~12~O~2~          −0.8          151.0765               151.0763    1891           133.0677, 107.0520, 94.0274, 77.0394                                                                4-(Ethoxymethyl)phenol                                                                       Phenols                         \[[@B14]\]
  X37          23.89      C~14~H~14~O~2~S        −4            245.0642               245.0632    2498           139.0217                                                                                            Bis(4-hydroxybenzyl)sulfide                                                                  Phenols                         \[[@B14]\]
  X38          32.90      C~9~H~8~O~3~           −1            163.0401               163.0399    4130           145.0279, 135.0455, 119.0493, 91.0184, 77.0443, 65.0039                                             *p*-Hydroxycinnamic acid                                                                     Organic acids                    
  X39          39.73      C~16~H~22~O~4~         −0.2          277.1445               277.1445    5380           233.1544, 206.8262                                                                                  Dibutyl phthalate                                                                            Phenols                          
  Peak         RT (min)   Formula                Error (ppm)   \[M+H\]^+^ (*m*/*z*)   Intensity   Product ions   Identification                                                                                      Structure class                                                                              Ref.                            
  Calculated   Measure                                                                                                                                                                                                                                                                                                                            
  Y1^a,b^      1.05       C~5~H~5~N~5~           −1.8          136.0618               136.0615    46698          nd                                                                                                  Adenine                                                                                      Nitrogen-containing compounds    
  Y2           1.08       C~10~H~13~N~5~O~4~     1.5           268.1040               268.1044    174357         136.0623, 119.0360,                                                                                 Adenosine                                                                                    Nitrogen-containing compounds    
  Y3^b^        1.09       C~9~H~11~NO~3~         −1.9          182.0812               182.0808    34675          nd                                                                                                  Tyrosin                                                                                      Nitrogen-containing compounds    
  Y4           8.60       C~24~H~29~N~3~O~8~S    −0.5          520.1748               520.1746    7896           308.0836, 285.0913, 233.0591, 179.0486, 162.0208, 107.0485                                          (2)-g-L-\[N-(4-Hydroxy benzyl)\]glutamyl-L-\[s-(4-hydroxybenzyl)\] cysteinylglycine          Nitrogen-containing compounds    
  Y5           9.77       C~10~H~8~O~4~          −0.8          193.0495               193.0494    14081          178.0257, 150.0323, 133.0281, 122.0361                                                              3-Carboxyethyl-phthalide                                                                     Organic acids                   \[[@B16]\]
  Y6           10.55      C~12~H~18~O~5~         −0.1          243.1227               243.1227    13011          165.0909, 151.0381, 137.0949                                                                        3-Butyl-3-hydroxy-4,5,6,7-tetrahydro-6,7-dihydroxy phthalide                                 Organic acids                    
  Y7           10.55      C~12~H~16~O~4~         −0.5          225.1121               225.1119    21174          207.1023, 165.0557, 151.0376, 137.0954                                                              Senkyunolide H or I or ligustilidiol or *cis*-6,7-dihydroxy-ligustilide                      Phthalides                      \[[@B9]\]
  Y8           11.94      C~12~H~16~O~5~         −0.8          241.1071               241.1069    1918           150.0677, 107.0497, 71.0498                                                                         Senkyunolide R or S                                                                          Phthalides                       
  Y9           13.27      C~12~H~16~O~3~         0.1           209.1172               209.1172    288915         153.0544, 149.0593, 135.0473, 121.1006, 117.0709                                                    Senkyunolide G or K or Z-6,7-epoxyligustilide                                                Phthalides                      \[[@B9]\]
  Y10          13.27      C~12~H~18~O~4~         0.4           227.1278               227.1279    102387         163.1104, 153.0543, 149.0961, 119.0860, 107.0484, 79.054                                            Senkyunolide J or N or R2                                                                    Phthalides                      \[[@B9]\]
  Y11          16.56      C~12~H~14~O~3~         −0.6          207.1016               207.1015    1327567        189.0917, 165.0550, 146.0732, 133.0653, 119.0841, 105.0693                                          3-Butylidene-6-hydroxy-5,6-dihy-drophthalide or senkyunolide F or chuanxiongol               Phthalides                      \[[@B9]\]
  Y12          16.57      C~12~H~16~O~4~         −0.9          225.1121               225.1119    39845          165.0533, 133.0658, 128.0619, 91.0532, 77.0402                                                      Senkyunolide H or I or ligustilidiol or *cis*-6,7-dihydroxy-ligustilide                      Phthalides                      \[[@B9]\]
  Y13          17.87      C~12~H~14~O~4~         −0.2          223.0965               223.0966    23855          177.0921, 149.0591, 121.0308, 103.0523, 77.0401                                                     Senkyunolide D or 4,7-dihydroxy-3-butylphthalide                                             Phthalides                      \[[@B9]\]
  Y14          18.08      C~12~H~14~O~3~         −0.1          207.1016               207.1015    425060         189.0901, 165.0558, 161.0948, 128.0620, 105.0701, 91.0549, 77.0393                                  3-Butylidene-6-hydroxy-5,6-dihy-drophthalide or senkyunolide F or chuanxiongol               Phthalides                      \[[@B9]\]
  Y15          19.53      C~18~H~28~O~8~         0.3           373.1857               373.1858    45450          211.1335, 193.1228, 147.1172, 105.0702, 79.0577                                                     Ligusticoside A                                                                              Glycosides                      \[[@B17]\]
  Y16          21.97      C~12~H~12~O~2~         −0.5          189.0910               189.0910    151946         128.0623, 115.0544, 105.0702, 91.0551, 77.0388                                                      Butylidenephthalide isomer                                                                   Phthalides                      \[[@B9]\]
  Y17          23.67      C~12~H~14~O~4~         0.3           223.0965               223.0966    43428          177.0899, 167.0387, 149.0227, 121.0278, 91.0541, 77.0382                                            Senkyunolide D or 4,7-dihydroxy-3-butylphthalide                                             Phthalides                      \[[@B9]\]
  Y18          24.29      C~12~H~12~O~2~         0             189.0910               189.0910    305525         152.0611, 128.0618, 115.0529, 105.0341, 91.0537, 77.0394                                            Butylidenephthalide isomer                                                                   Phthalides                      \[[@B9]\]
  Y19          24.50      C~12~H~14~O~2~         −0.9          191.1067               191.1067    340079         117.0688, 91.0560, 77.0396                                                                          3-Butylphthalide or Z-ligustilide or E-ligustilide                                           Phthalides                      \[[@B9]\]
  Y20          26.27      C~12~H~15~ClO~3~       −0.5          243.0783               243.0781    21244          207.1020, 189.0907, 161.0364, 133.0640, 119.0840, 91.0533,                                          Senkyunolide L                                                                               Phthalides                      \[[@B18]\]
  Y21          26.63      C~12~H~12~O~3~         0.6           205.0859               205.0860    90627          187.0745, 168.0574, 144.0573, 131.0493, 115.0541, 103.0552, 91.0533, 77.0401                        Senkyunolide B or C                                                                          Phthalides                      \[[@B9]\]
  Y22          27.74      C~13~H~16~O~3~         −0.6          221.1172               221.1171    4804           175.1090, 105.0691                                                                                  2-(1-Oxopentyl)-benzoic                                                                      Organic acids                    
  Y23          27.90      C~12~H~12~O~3~         0.6           205.0859               205.0860    90627          187.0745, 168.0574, 144.0573, 131.0493, 115.0541, 103.0552, 91.0533, 77.0401                        Senkyunolide B or C                                                                          Phthalides                      \[[@B9]\]
  Y24          28.65      C~12~H~16~O~2~         0.7           193.1223               193.1225    2273337        147.1167, 137.0590, 119.0498, 105.0699, 91.0544, 77.0389, 65.0383                                   Senkyunolide A                                                                               Phthalides                      \[[@B9]\]
  Y25          29.49      C~12~H~14~O~2~         0.3           191.1067               191.1067    3489472        153.0704, 145.1007, 135.0440, 117.0695, 91.0546, 77.0391                                            3-Butylphthalide or Z-ligustilide or E-ligustilide                                           Phthalides                      \[[@B9]\]
  Y26          32.06      C~12~H~12~O~2~         −0.5          189.0910               189.0910    39396          152.0611, 128.0615, 115.0545, 91.0554                                                               Butylidenephthalide isomer                                                                   Phthalides                      \[[@B9]\]
  Y27^b^       32.89      C~12~H~18~O~2~         −0.8          195.1380               195.1378    686098         177.1344, 149.1309, 79.0550                                                                         Cnidilide or neocnilide                                                                      Phthalides                      \[[@B9]\]
  Y28          33.04      C~12~H~14~O~2~         0.3           191.1067               191.1067    637725         173.0961, 145.1008, 130.0773, 117.0694, 91.0548, 77.0392                                            3-Butylphthalide or Z-ligustilide or E-ligustilide                                           Phthalides                      \[[@B9]\]
  Y29          33.64      C~12~H~12~O~2~         −0.2          189.0910               189.0910    401466         152.0627, 128.0622, 115.0540, 91.0550                                                               Butylidenephthalide isomer                                                                   Phthalides                      \[[@B9]\]
  Y30          35.24      C~12~H~20~O~2~         −0.7          197.1536               197.1535    21102          119.0862, 95.0856, 91.0555, 81.0697, 67.0552,                                                       3,7-Dimethyl-3-acetate-1,6-octadiene-3-ol acetate                                            Others                           
  Y31          36.15      C~21~H~32~O~2~         0.9           317.2475               317.2478    12477          281.2253, 211.1524, 187.1501, 159.1179, 149.1329, 145.0997, 117.0717, 81.0720                       Pregnenolone                                                                                 Others                           
  Y32          36.37      C~24~H~28~O~5~         0.1           397.2010               397.2010    71592          191.1064, 173.0954, 155.0852, 145.1003, 128.0625, 117.0715, 105.0724, 91.0544                       Chuanxiongnolide A or B                                                                      Others                          \[[@B19]\]
  Y33          38.22      C~24~H~28~O~5~         0.4           397.2010               397.2010    66600          361.1802, 333.1842, 307.1708, 291.1401, 279.1403, 261.1264,2 17.0999, 191.1070, 173.0972, 91.0553   Chuanxiongnolide A or B                                                                      Others                          \[[@B19]\]
  Y34          39.08      C~24~H~32~O~5~         −0.4          401.2323               401.2321    20533          383.2246, 191.1061, 163.1084, 149.0594, 145.1037, 135.0439                                          Chuanxiongdiolide R2 or chuanxiongdiolide B                                                  Others                          \[[@B20]\]
  Y35          39.48      C~17~H~24~O~4~         0.8           293.1747               293.1750    22471          175.1115, 151.0754, 137.0605, 111.0415, 91.0547, 83.0488                                            Senkyunolide M or Q                                                                          Phthalides                      \[[@B9]\]
  Y36          41.42      C~24~H~30~O~4~         −0.1          383.2217               383.2217    1160225        191.1068, 173.0958, 163.1120, 149.0601, 135.0440, 91.0546, 79.0566                                  Senkyunolide P or 3,8-dihydro-diligustilide or angelicide or Z,Z′−3,3′ −8,8′-diligustilide   Phthalides                      \[[@B9]\]
  Y37          41.52      C~24~H~32~O~4~         0.1           385.2373               385.2374    627373         367.2247, 349.2092, 321.2178, 293.1915, 193.1229, 175.1113147.1159, 137.0587, 119.0871, 93.0687     Chuanxiongdiolide A                                                                          Others                          \[[@B20]\]
  Y38          41.88      C~24~H~28~O~4~         0.1           381.2060               381.2061    4796897        191.1070, 173.0955, 163.1126, 149.0596, 135.0437, 91.0551, 79.0549                                  Levistolide A or senkyunolide O or tokinolide B or riligustilide                             Phthalides                      \[[@B9]\]

^a^"X" in negative ion mode and "Y" in negative-positive mode. ^b^Compared with reference standards.

###### 

Metabolites identified in plasma of rats after oral administration by UPLC/Q-TOF MS.

  No.   Parent compounds                                               Metabolic pathways                          Formula                tR (min)   \[M+H\]^+^ (*m*/*z*)   Error (ppm)   Product ions   
  ----- -------------------------------------------------------------- ------------------------------------------- ---------------------- ---------- ---------------------- ------------- -------------- --------------------------------------------------------------------------------------------------------------
  1     4,7-Dihydroxy-3-butylphthalide, senkyunolide D                 Prototype                                   C~12~H~14~O~4~         9.75       223.0965               223.0963      −1             177.0899, 167.0387, 149.0226, 121.0278, 91.0541
  2     4,7-Dihydroxy-3-butylphthalide, senkyunolide D                 Hydroxyl and methyl conjugation             C~13~H~16~O~5~         10.78      253.1071               253.1071      0.2            235.0963, 221.0829, 202.0596, 193.0489, 179.0332, 175.0379, 150.0301, 121.0268
  3     4,7-Dihydroxy-3-butylphthalide, senkyunolide D                 Sulfate conjugation                         C~12~H~14S~O~7~        9.2        303.0533               303.0535      0.5            285.0430, 205.0858, 187.0753, 177.0904, 149.0244, 121.0283, 91.0534
  4     4,7-Dihydroxy-3-butylphthalide, senkyunolide D                 Glucuronide conjugation                     C~18~H~22~O~10~        10.6       399.1286               399.1285      −0.3           223.0969, 205.0847, 177.0883, 167.0331, 149.0233, 121.0315
  5     4,7-Dihydroxy-3-butylphthalide, senkyunolide D                 Hydrogenation and glucuronide conjugation   C~18~H~24~O~10~        8.67       401.1442               401.1444      0.3            225.4427, 207.1017, 189.0924, 172.0884, 165.0548, 141.0170, 119.0851, 113.0288
  6     4,7-Dihydroxy-3-butylphthalide, senkyunolide D                 Hydroxyl and glucuronide conjugation        C~18~H~22~O~11~        8.92       415.1235               415.1238      0.7            227.0584, 221.0824, 167.0331
  7     3-Butyl-3-hydroxy-4,5,6,7-tetrahy-dro-6,7-dihydroxyphthalide   Prototype                                   C~12~H~18~O~5~         7.76       243.1227               243.1225      −0.7           165.0909, 151.0414, 137.0951, 123.0431, 107.0499, 91.0546, 85.0648
  8     3-Butyl-3-hydroxy-4,5,6,7-tetrahy-dro-6,7-dihydroxyphthalide   Methyl conjugation                          C~13~H~20~O~5~         10.01      257.1384               257.1381      −1             221.1211, 207.0993, 165.0913, 137.0951, 123.0434
  9     3-Butyl-3-hydroxy-4,5,6,7-tetrahy-dro-6,7-dihydroxyphthalide   Cystein conjugation                         C~15~H~23~O~6~NS       7.67       346.1319               346.1319      0              328.1222, 310.1111, 264.1056, 238.0916, 223.0771, 207.1018, 165.0923, 137.0955
  10    3-Butyl-3-hydroxy-4,5,6,7-tetrahy-dro-6,7-dihydroxyphthalide   Oxidation and cystein conjugation           C~15~H~23~O~7~NS       9.47       362.1268               362.1267      −0.3           327.0911, 247.1337, 229.1216, 151.0746
  11    3-Butyl-3-hydroxy-4,5,6,7-tetrahy-dro-6,7-dihydroxyphthalide   *N*-Acetyl-L-cysteine conjugation           C~17~H~25~O~8~NS       5.97       404.1374               404.1372      −0.5           205.0833, 171.1364
  12    3-Butyl-3-hydroxy-4,5,6,7-tetrahy-dro-6,7-dihydroxyphthalide   Desat and S-GSH conjugation                 C~22~H~33~O~11~N~3S~   4.39       548.1909               548.1921      2.3            473.1636, 419.1465, 205.0860
  13    3-Butyl-3-hydroxy-4,5,6,7-tetrahy-dro-6,7-dihydroxyphthalide   H~2~O conjugation                           C~12~H~20~O~6~         4.65       261.1333               261.1320      −4.6           261.1310
  14    3-Carboxyethyl-phthalide                                       Prototype                                   C~10~H~8~O~4~          7.28       193.0495               193.0490      −2.7           178.0257, 150.0323, 133.0277, 122.0361, 105.0338, 77.0388
  15    3-Carboxyethyl-phthalide                                       Methyl conjugation                          C~11~H~10~O~4~         11.52      207.0652               207.0646      −3             147.0441, 131.0502, 103.0546, 91.0533
  16    3-Carboxyethyl-phthalide                                       Glucuronide conjugation                     C~16~H~16~O~10~        5.51       369.0816               369.0822      1.5            193.0493
  17    3-Carboxyethyl-phthalide                                       Hydroxyl and glucuronide conjugation        C~16~H~16~O~11~        5.72       385.0765               385.0758      −2.1           209.0455
  18    3-Carboxyethyl-phthalide                                       Hydrogenation                               C~10~H~10~O~4~         7.64       195.0652               195.0651      −0.6           177.0547, 149.0609, 145.0276, 134.0354, 117.0309, 89.0395
  19    Cnidilide, neocnilide                                          Prototype                                   C~12~H~18~O~2~         16.14      195.1380               195.1377      −1.5           177.1350, 149.1348, 125.0599, 107.0873, 97.0640, 91.0550, 79.0543
  20    Cnidilide, neocnilide                                          Methyl conjugation                          C~13~H~20~O~2~         15.63      209.1536               209.1537      0.4            193.0211, 167.1088, 153.0917, 121.0648, 68.9961
  21    Cnidilide, neocnilide                                          Acetyl conjugation                          C~14~H~20~O~3~         12.45      237.1485               237.1483      −1.1           177.0257
  22    Cnidilide, neocnilide                                          Hydroxyl and acetyl conjugation             C~14~H~20~O~4~         12.46      253.1434               253.1435      0.4            235.1340, 193.0856, 157.1012, 135.0816
  23    Cnidilide, neocnilide                                          Oxidation and cystein conjugation           C~15~H~23~O~4~NS       10.07      314.1421               314.1424      1.1            268.1343, 193.1185
  24    Cnidilide, neocnilide                                          Hydroxyl and glucuronide conjugation        C~18~H~26~O~9~         9.62       387.1650               387.1650      0.1            211.1330, 193.1223, 175.1129, 147.1168, 121.0368
  25    Cnidilide, neocnilide                                          2Hydroxyl and glucuronide conjugation       C~18~H~26~O~10~        8.02       403.1599               403.1598      −0.2           227.1287, 209.1174, 191.1065, 171.1373, 163.1123, 153.0549, 145.1025, 141.0186, 135.1164, 121.0995
  26    Cnidilide, neocnilide                                          2Hydroxyl conjugation                       C~12~H~18~O~4~         8.68       227.1278               227.1279      0.7            191.1057, 163.1115, 153.0554, 145.1001, 135.0444, 105.0705, 91.0541
  27    Senkyunolide A                                                 Prototype                                   C~12~H~16~O~2~         14.81      193.1223               193.1222      −0.5           175.1118, 147.1170, 137.0580, 119.0848, 105.0710, 91.0556, 77.0393
  28    Senkyunolide A                                                 Hydroxyl and methyl conjugation             C~13~H~18~O~3~         15.85      223.1329               223.1326      −1.2           205.1224, 191.1060, 149.0235, 135.0429, 121.0279, 105.0697, 91.0542, 77.0397
  29    Senkyunolide A                                                 Hydroxyl and acetylcysteine conjugation     C~17~H~25~O~6~NS       10.35      372.1475               372.1475      −0.1           330.1375, 284.1322, 267.1048.239.0756, 209.1169, 191.1074, 162.0210, 153.0540, 130.0492
  30    Senkyunolide A                                                 Carboxyl and glucuronide conjugation        C~18~H~22~O~10~        10.6       399.1286               399.1285      −0.3           223.0969, 205.0847, 177.0883, 159.0293, 149.0233, 131.0840, 85.0275
  31    Senkyunolide A                                                 2Hydroxyl and glucuronide conjugation       C~18~H~24~O~10~        8.67       401.1442               401.1444      0.3            225.1127, 207.1017, 189.0924, 172.0884, 165.0548, 141.0170, 119.0851, 113.0288, 85.0265, 73.0295
  32    Senkyunolide A                                                 H~2~O conjugation                           C~12~H~18~O~3~         10.54      211.1329               211.1327      −0.9           193.1225, 175.1096, 147.1156, 129.0700, 105.0693, 93.0692, 79.0548
  33    Senkyunolide A                                                 2Hydroxyl conjugation                       C~12~H~16~O~4~         9.56       225.1121               225.1119      −1             207.1013, 189.0914, 165.0537, 133.0637, 105.0706, 91.0536, 81.0713
  34    Senkyunolide G, senkyunolide K,Z-6,7-epoxyligustilide          Prototype                                   C~12~H~16~O~3~         12.79      209.1172               209.1173      0.3            153.0686, 149.0594, 145.0984, 135.0472, 105.0693, 91.0562, 77.0409
  35    Senkyunolide G, senkyunolide K,Z-6,7-epoxyligustilide          Methyl conjugation                          C~13~H~18~O~3~         15.85      223.1329               223.1326      −1.2           191.1060, 173.0946, 149.0235, 145.1014, 135.0429, 105.0697, 91.0542, 79.0551
  36    Senkyunolide G, senkyunolide K,Z-6,7-epoxyligustilide          Acetyl conjugation                          C~14~H~18~O~4~         15.99      251.1278               251.1276      −0.6           177.1261, 149.0593, 69.0014, 57.0752
  37    Senkyunolide G, senkyunolide K,Z-6,7-epoxyligustilide          Hydroxyl and acetyl conjugation             C~14~H~18~O~5~         12.27      267.1227               267.1226      −0.4           249.1137, 193.0479, 189.0582, 135.0435, 119.0846
  38    Senkyunolide G, senkyunolide K,Z-6,7-epoxyligustilide          Taurine conjugation                         C~15~H~21~O~5~NS       9.02       328.1213               328.1214      0.1            207.1015, 189.0911, 165.0541, 161.0955, 147.0814, 133.0644, 119.0859, 91.0538
  39    Senkyunolide G, senkyunolide K,Z-6,7-epoxyligustilide          *N*-Acetyl-L-cysteine conjugation           C~17~H~23~O~6~NS       11.15      370.1319               370.1320      0.3            282.1162, 264.1083, 207.1015, 189.0911, 165.0544, 147.0785, 133.0652, 119.0858, 91.0546
  40    Senkyunolide G, senkyunolide K,Z-6,7-epoxyligustilide          Hydrogenation and glucuronide conjugation   C~18~H~26~O~9~         9.62       387.1650               387.1650      0.1            211.1330, 193.1223, 175.1129, 147.1168, 121.0638, 91.0546, 79.0562
  41    Senkyunolide G, senkyunolide K,Z-6,7-epoxyligustilide          Hydroxyl and acetylcysteine conjugation     C~17~H~25~O~7~NS       8.29       388.1425               388.1422      −0.6           207.1010, 164.0390, 122.0273, 105.0347, 79.0529
  42    Senkyunolide G, senkyunolide K,Z-6,7-epoxyligustilide          Hydroxyl and glucuronide conjugation        C~18~H~24~O~10~        8.67       401.1442               401.1444      0.3            267.1015, 225.1127, 207.1017, 189.0924, 172.0844, 141.0170, 113.0228, 85.0265, 73.0295
  43    Senkyunolide G, senkyunolide K,Z-6,7-epoxyligustilide          Carboxyl and glucuronide conjugation        C~18~H~22~O~11~        8.92       415.1235               415.1238      0.7            227.0584, 221.0824
  44    Senkyunolide G, senkyunolide K,Z-6,7-epoxyligustilide          Desat and S-GSH conjugation                 C~22~H~31~O~9~N~3~S    9.17       514.1854               514.1854      0              439.1552, 385.1429, 282.1160, 207.1017, 189.0921, 179.0484, 162.0221, 144.0103, 116.0174, 76.0218
  45    Senkyunolide G, senkyunolide K,Z-6,7-epoxyligustilide          S-GSH conjugation                           C~22~H~33~O~9~N~3~S    8.61       516.2010               516.2010      −0.1           441.1694, 387.1593, 284.1315, 209.1173, 191.1055, 162.0212, 144.0109, 116.0175, 84.0447
  46    Senkyunolide G, senkyunolide K,Z-6,7-epoxyligustilide          Hydrogenation                               C~12~H~18~O~3~         10.54      211.1329               211.1327      −0.9           193.1225, 175.1096, 151.0737, 147.1156, 129.0700, 121.0641, 105.0693, 93.0693, 91.0546, 77.0398
  47    Senkyunolide G, senkyunolide K,Z-6,7-epoxyligustilide          Hydroxyl and demethyl conjugation           C~12~H~14~O~4~         9.75       223.0965               223.0963      −1             177.0906, 149.0590, 145.0980, 105.0329, 91.0556, 77.0394
  48    Senkyunolide G, senkyunolide K,Z-6,7-epoxyligustilide          H~2~O conjugation                           C~12~H~18~O~4~         8.68       227.1278               227.1279      0.7            209.1169, 191.1057, 163.1115, 153.0554, 145.1001, 135.0444, 105.0705, 91.0541, 77.0388, 65.0402, 55.0198
  49    Senkyunolide G, senkyunolide K,Z-6,7-epoxyligustilide          Demethyl and carboxyl conjugation           C~12~H~14~O~5~         9.79       239.0914               239.0915      0.4            221.0816, 193.0885, 179.0336, 165.0173, 161.0227, 128.0633, 109.0292, 77.0376
  50    Senkyunolide G, senkyunolide K,Z-6,7-epoxyligustilide          2hydrogenation and 2hydroxyl conjugation    C~12~H~18~O~5~         7.76       243.1227               243.1225      −0.7           225.1135, 207.1017, 179.1084, 165.0909, 151.0414, 137.0951, 123.0431, 95.0486
  51    Senkyunolide G, senkyunolide K,Z-6,7-epoxyligustilide          Aromatic hydrocarbon oxidation              C~13~H~18~O~5~         11.38      255.1227               255.1222      −2.1           195.1024, 135.0798, 131.0870
  52    Senkyunolide J,N,R2                                            Prototype                                   C~12~H~18~O~4~         8.68       227.1278               227.1279      0.7            163.1115, 153.0554, 145.1001, 107.0705, 91.0541, 79.0544, 65.0402, 55.0198
  53    Senkyunolide J,N,R2                                            Methyl conjugation                          C~13~H~20~O~4~         11.42      241.1434               241.1433      −0.6           209.1147, 191.1067, 163.1089, 153.0559, 121.0652, 93.0717, 85.0663, 79.0663, 57.0698
  54    Senkyunolide J,N,R2                                            Hydroxyl and methyl conjugation             C~13~H~20~O~5~         10.01      257.1384               257.1381      −1             221.1211, 207.0993, 165.0913, 161.0984, 137.0951, 123.0434, 93.0699, 79.0549, 67.0538
  55    Senkyunolide J,N,R2                                            Glycine conjugation                         C~14~H~21~O~5~N        7.49       284.1493               284.1495      0.8            238.1464, 209.1195, 191.1065, 163.1151, 153.0546, 135.1157, 117.0704, 91.0562, 76.0410, 57.0711
  56    Senkyunolide J,N,R2                                            Cystein conjugation                         C~15~H~23~O~5~NS       8.48       330.1370               330.1375      1.7            284.1324, 209.1176, 191.1066, 163.1120, 153.0544, 145.1015, 121.1008, 93.0695, 85.0650
  57    Senkyunolide J,N,R2                                            Taurine conjugation                         C~14~H~23~O~6~NS       7.56       334.1319               334.1319      0              209.1147, 181.1211, 153.0555, 126.0211, 108.0102, 91.0549
  58    Senkyunolide J,N,R2                                            Oxidation and cystein conjugation           C~15~H~23~O~6~NS       7.67       346.1319               346.1319      0              328.1222, 310.1111, 264.1056, 238.0916, 207.1018, 195.0853, 165.0923, 137.0955
  59    Senkyunolide J,N,R2                                            *N*-Acetyl-L-cysteine conjugation           C~17~H~25~O~7~NS       8.29       388.1425               388.1422      −0.6           207.1010, 164.0390, 107.0491, 122.0273, 105.0347
  60    Senkyunolide J,N,R2                                            Glucuronide conjugation                     C~18~H~26~O~10~        8.02       403.1599               403.1598      −0.2           227.1287, 209.1174, 191.1065, 163.1123, 153.0549, 145.1025, 135.1164, 121.0995, 93.0712
  61    Senkyunolide J,N,R2                                            S-GSH conjugation                           C~22~H~35~O~10~N~3~S   4.96       534.2116               534.2113      −0.6           459.1795, 405.1696, 387.1582, 369.1490, 341.1469, 302.1438, 284.1303, 284.1303, 241.0913, 209.1157, 191.1075

[^1]: Academic Editor: Eliseo Herrero-Hernández
